Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer

Thomas Regenbogen1, Ling Chen, Kathryn Trinkaus

  • 1Division of Oncology, Washington University, St. Louis, MO, USA.

Abstract

Insights

Pacritinib, a JAK/STAT inhibitor, showed no objective responses in refractory colorectal cancer patients. The trial was halted due to limited benefit and an FDA hold, indicating poor efficacy for this patient group.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pharmacology

Background:

  • Limited treatment options exist for refractory colorectal cancer.
  • The JAK/STAT pathway is implicated in cancer inflammation.
  • Pacritinib targets the JAK/STAT pathway.

Purpose of the Study:

  • To evaluate pacritinib's efficacy in metastatic refractory colorectal adenocarcinoma.
  • To assess the inhibition of the JAK/STAT pathway as a therapeutic strategy.

Main Methods:

  • Single-arm institutional trial.
  • Administered pacritinib 400 mg daily orally.
  • Enrolled patients refractory to at least two prior treatments.

Main Results:

  • Trial discontinued early due to FDA hold and lack of benefit.
  • Seven patients evaluated; one had stable disease, six progressed.
  • No objective responses observed; adverse events were grade 2 or lower.

Conclusions:

  • Pacritinib demonstrated no objective responses in evaluable patients.
  • Trial halted due to low likelihood of meeting progression-free survival goals.
  • Further investigation of pacritinib in this setting is not supported.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.9K
Assessing Body Temperature - Rectal01:27

Assessing Body Temperature - Rectal

Rectal temperature measurement is considered the most precise method for assessing core body temperature and typically registers higher than oral temperature. For adults, the rectal thermometer should be inserted 1 to 1.5 inches into the rectum to obtain the most accurate reading.
Follow these steps for rectal temperature assessment:
Step 1: Perform hand hygiene and don clean gloves to prevent cross-infection.
Step 2: Position the patient in a side-lying position to better visualize the rectal...
12.8K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K